Routine

Anaemia of chronic disease (anaemia of inflammation; anaemia of chronic disorders, ACD)

Anaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Hepcidin-driven iron sequestration and blunted erythropoiesis from chronic infection, inflammation, malignancy or CKD. Usually mild-moderate normocytic (sometimes microcytic) anaemia with LOW serum iron but NORMAL/HIGH ferritin. Treat the underlying disease; iron and ESAs only in selected cases.

Red flags

  • Rapidly worsening anaemia (suggests bleeding or marrow process, not ACD)
  • Very low MCV / very high ferritin discordant with picture - reconsider diagnosis
  • Weight loss, night sweats, lymphadenopathy (occult malignancy)
  • New anaemia with renal failure and bone pain (myeloma)

Assessment

Differential diagnosis

  • Iron-deficiency anaemia (ferritin low, TIBC high)
  • Combined ACD + iron deficiency
  • Anaemia of CKD (EPO deficiency)
  • Thalassaemia trait
  • Myelodysplasia, marrow infiltration
  • Haemolysis, B12/folate deficiency

Investigations

  • FBC + MCV + reticulocytes (low/normal retic, normocytic or mildly microcytic)
  • Iron studies: serum iron low, TIBC/transferrin low-normal, transferrin saturation low, ferritin normal or high (acute phase)
  • CRP/ESR (inflammation), renal function
  • Blood film; exclude bleeding (coeliac screen, FIT/endoscopy if iron deficiency suspected)
  • Identify underlying disorder: infection screen, autoimmune/malignancy workup as indicated
  • Consider soluble transferrin receptor or sTfR/log ferritin index if coexisting iron deficiency unclear

Management

  • Confirm the pattern (low iron, non-low ferritin) and exclude concurrent true iron deficiency / blood loss
  • Direct treatment at the underlying condition - this is the definitive therapy
  • Reserve blood transfusion for symptomatic/severe anaemia or cardiovascular compromise; use restrictive thresholds
  • In CKD or chemotherapy-related anaemia, consider erythropoiesis-stimulating agents under specialist guidance (ensure iron replete, caution re: thrombosis/BP/tumour outcomes)
  • Give iron (preferably IV) only if coexisting absolute/functional iron deficiency demonstrated
  • Avoid reflex long-term oral iron when ferritin is high - ineffective due to hepcidin block

Drugs & doses

Treat underlying cause (antimicrobials, immunosuppression, cancer therapy) - no specific anaemia drug for pure ACD
IV iron (e.g. ferric carboxymaltose 1000 mg IV, dose by weight/Hb deficit) only if functional/absolute iron deficiency coexists [verify local dose]
Erythropoiesis-stimulating agent (e.g. epoetin / darbepoetin) in CKD or chemo-anaemia per specialist protocol, target Hb ~100-120 g/L, avoid overshoot [verify local dose]
Transfuse packed red cells only for symptomatic severe anaemia (restrictive threshold, typically Hb <70 g/L or <80 if cardiac disease)

Disposition

Usually outpatient - investigate and treat the underlying cause via GP/relevant specialty. Admit only for severe symptomatic anaemia or the underlying illness.

Complications & pitfalls

  • Symptomatic anaemia impairing cardiac/functional status
  • Masked coexisting iron deficiency
  • ESA-related thrombosis / hypertension / worse tumour outcomes if overtreated

Exam pearls

  • Ferritin is an acute-phase reactant - a 'normal' ferritin in inflammation does NOT exclude iron deficiency; transferrin saturation and sTfR help
  • ACD anaemia is usually mild (Hb 80-110 g/L) - severe anaemia warrants a second diagnosis
  • Treat the disease, not the number - routine iron/ESAs are not first-line for pure ACD
  • Oral iron is poorly absorbed when hepcidin is high; IV iron preferred if truly deficient

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.